연구성과로 돌아가기

2023 연구자 정보 (936 / 1135)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 교신저자 여부 Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Avallone, Antonio
(Avallone, A)
IRCCS Fdn G Pascale, Ist Nazl Tumori, Dept Abdominal Oncol, I-80131 Naples, Italy K-4662-2016
Avallone, Antonio
0000-0001-6188-5664
Avallone, Antonio
[JCR상위 43.9] KEYSTEP-008: phase II trial of pembrolizumab-based combination in MSI-H/dMMR metastatic colorectal cancer SCIE 43.9 ONCOLOGY thierry.andre@aphp.fr;
Avramov, P.
(Avramov, P)
제1저자 Kyungpook Natl Univ, Dept Chem, Daegu, South Korea

[JCR상위 43.9] Topology Conservation Theorem, Quantum Instability and Violation of Subperiodic Symmetry of Complex Low-Dimensional Lattices SCIE 43.9 CHEMISTRY, MULTIDISCIPLINARY;CRYSTALLOGRAPHY
Fogelman, David
(Fogelman, D)
Merck & Co Inc, Rahway, NJ USA

[JCR상위 43.9] KEYSTEP-008: phase II trial of pembrolizumab-based combination in MSI-H/dMMR metastatic colorectal cancer SCIE 43.9 ONCOLOGY thierry.andre@aphp.fr;
Gumus, Mahmut
(Gumus, M)
Istanbul Medeniyet Univ, Goztepe Prof Dr Suleyman Yalcin City Hosp, Dept Med Oncol, TR-34700 Istanbul, Turkiye HTO-4176-2023
Gumus, Mahmut
0000-0003-3550-9993
Gumus, Mahmut
[JCR상위 43.9] KEYSTEP-008: phase II trial of pembrolizumab-based combination in MSI-H/dMMR metastatic colorectal cancer SCIE 43.9 ONCOLOGY thierry.andre@aphp.fr;
Kim, Tae Won
(Kim, TW)
Univ Ulsan, Asan Med Ctr, Dept Oncol, Coll Med, Seoul 05505, South Korea
Univ Ulsan, Asan Med Ctr, Dept Oncol, Coll Med, Seoul, South Korea
Univ Ulsan, Asan Med Ctr, Dept Oncol, Seoul, South Korea
GRX-7323-2022
Kim, Tae Won

[JCR상위 43.9] KEYSTEP-008: phase II trial of pembrolizumab-based combination in MSI-H/dMMR metastatic colorectal cancer
[JCR상위 28.4] Recommendations for the Use of Next-Generation Sequencing and the Molecular Tumor Board for Patients with Advanced Cancer: A Report from KSMO and KCSG Precision Medicine Networking Group (vol 54, pg 1, 2022)
[JCR상위 81.5] Prospective, open-label, and observational study of cetuximab for metastatic colorectal carcinoma: The OPTIM1SE study
SCIE 28.4 ONCOLOGY thierry.andre@aphp.fr;
pys27hmo@skku.edu;
Kwiatkowski, Mariusz
(Kwiatkowski, M)
Szpital Wojewodzki Mikolaja Kopern Koszalinie, Dept Oddzial Dzienny Chemioterapii, PL-75581 Koszalin, Poland

[JCR상위 43.9] KEYSTEP-008: phase II trial of pembrolizumab-based combination in MSI-H/dMMR metastatic colorectal cancer SCIE 43.9 ONCOLOGY thierry.andre@aphp.fr;
Leconte, Pierre
(Leconte, P)
MSD France, Dept Med Oncol, F-92800 Puteaux La Defense, France

[JCR상위 43.9] KEYSTEP-008: phase II trial of pembrolizumab-based combination in MSI-H/dMMR metastatic colorectal cancer SCIE 43.9 ONCOLOGY thierry.andre@aphp.fr;
Lonardi, Sara
(Lonardi, S)
Veneto Inst Oncol IRCCS, Dept Oncol, I-31033 Padua, Italy F-4228-2014
Lonardi, Sara

[JCR상위 43.9] KEYSTEP-008: phase II trial of pembrolizumab-based combination in MSI-H/dMMR metastatic colorectal cancer SCIE 43.9 ONCOLOGY thierry.andre@aphp.fr;
Odeleye-Ajakaye, Amos
(Odeleye-Ajakaye, A)
Merck & Co Inc, Rahway, NJ USA

[JCR상위 43.9] KEYSTEP-008: phase II trial of pembrolizumab-based combination in MSI-H/dMMR metastatic colorectal cancer SCIE 43.9 ONCOLOGY thierry.andre@aphp.fr;
Pietrantonio, Filippo
(Pietrantonio, F)
Fdn IRCCS Ist Nazl Tumori, Med Oncol Dept, I-20133 Milan, Italy C-2180-2017
Pietrantonio, Filippo
0000-0002-8530-8420
Pietrantonio, Filippo
[JCR상위 43.9] KEYSTEP-008: phase II trial of pembrolizumab-based combination in MSI-H/dMMR metastatic colorectal cancer SCIE 43.9 ONCOLOGY thierry.andre@aphp.fr;
Rao, Purna Chandra
(Rao, PC)
제1저자 Kyungpook Natl Univ, Dept Chem, Daegu 41566, South Korea
Kyungpook Natl Univ, Green Nano Mat Res Ctr, Daegu 41566, South Korea
AHI-3532-2022
Rao, Purna Chandra
0000-0001-8549-0915
RAO, PURNA CHANDRA
[JCR상위 43.9] A new three-dimensional fluorene pyrazolate-based metal-organic framework featuring luminescence and electrical conductivity
[JCR상위 12.1] Methylbenzyl Naphthalene: Liquid Organic Hydrogen Carrier for Facile Hydrogen Storage and Release
SCIE 12.1 CHEMISTRY, MULTIDISCIPLINARY;CRYSTALLOGRAPHY
CHEMISTRY, MULTIDISCIPLINARY;ENGINEERING, CHEMICAL;GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY
purna@knu.ac.kr;
kyungsu_na@chonnam.ac.kr;myyoon@knu.ac.kr;
Wyrwicz, Lucjan
(Wyrwicz, L)
Narodowy Inst Onkol Marii Sklodowskiej Curie, Klin Onkol & Radioterapii, PL-00001 Warsaw, Poland

[JCR상위 43.9] KEYSTEP-008: phase II trial of pembrolizumab-based combination in MSI-H/dMMR metastatic colorectal cancer SCIE 43.9 ONCOLOGY thierry.andre@aphp.fr;
Yalcin, Suayib
(Yalcin, S)
Hacettepe Univ, Dept Med Oncol, TR-06230 Ankara, Turkiye KWT-7106-2024
Yalcin, Suayib

[JCR상위 43.9] KEYSTEP-008: phase II trial of pembrolizumab-based combination in MSI-H/dMMR metastatic colorectal cancer SCIE 43.9 ONCOLOGY thierry.andre@aphp.fr;
Zolnierek, Jakub
(Zolnierek, J)
LuxMed Onkol Warszawa, Ul Szamocka 6, PL-01748 Warsaw, Poland

[JCR상위 43.9] KEYSTEP-008: phase II trial of pembrolizumab-based combination in MSI-H/dMMR metastatic colorectal cancer SCIE 43.9 ONCOLOGY thierry.andre@aphp.fr;
Danish, Mohtaram
(Danish, M)
교신저자 Kyungpook Natl Univ, Sch Architecture Civil Environm & Energy Engn, 80 Daehak Ro, Daegu 41566, South Korea
0000-0002-2671-2562
Danish, Mohtaram
[JCR상위 44.1] State-of-the-art review on photocatalysis for efficient wastewater treatment: Attractive approach in photocatalyst design and parameters affecting the photocatalytic degradation SCIE 44.1 CHEMISTRY, PHYSICAL dmohtaram@gmail.com;wkjo@knu.ac.kr;
페이지 이동: